Atsuko Sakurai-Sangria
Expert Member Best Practices mRNA Centivax
Seminars
Thursday 26th February 2026
Case Study: Driving Analytical Robustness & CMC Readiness for Efficient Development of Novel RNA Modalities
11:30 am
- Navigating unique analytical and regulatory challenges when developing novel RNA-based vaccines
- Designing phase-appropriate QC and analytical strategies that can adapt as novel modalities progress toward GMP readiness
- How learnings from novel platforms can inform broader industry best practices in analytical robustness and CMC submissions
